Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 2
2001 2
2002 2
2003 4
2004 1
2005 2
2006 2
2007 1
2008 2
2009 3
2010 1
2011 4
2012 2
2013 2
2014 4
2015 3
2016 3
2017 1
2019 1
2020 2
2021 3
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 in ocrelizumab-treated people with multiple sclerosis.
Hughes R, Whitley L, Fitovski K, Schneble HM, Muros E, Sauter A, Craveiro L, Dillon P, Bonati U, Jessop N, Pedotti R, Koendgen H. Hughes R, et al. Among authors: pedotti r. Mult Scler Relat Disord. 2021 Apr;49:102725. doi: 10.1016/j.msard.2020.102725. Epub 2020 Dec 30. Mult Scler Relat Disord. 2021. PMID: 33482590 Free PMC article.
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
Guerrera G, Mandelli A, Finardi A, Orrico M, D'Orso S, Picozza M, Noviello M, Beretta V, Bonetti B, Calabrese M, Marastoni D, De Rossi N, Capra R, Salvetti M, Buscarinu MC, Inglese M, Uccelli A, Moiola L, Raposo C, Muros-Le Rouzic E, Pedotti R, Filippi M, Bonini C, Battistini L, Borsellino G, Furlan R. Guerrera G, et al. Among authors: pedotti r. Mult Scler. 2022 Oct;28(12):1937-1943. doi: 10.1177/13524585221102158. Epub 2022 Jun 20. Mult Scler. 2022. PMID: 35723265
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel.
Weberpals J, Roumpanis S, Barer Y, Ehrlich S, Jessop N, Pedotti R, Vaknin-Dembinsky A, Brill L, Chodick G, Rouzic EM. Weberpals J, et al. Among authors: pedotti r. Mult Scler Relat Disord. 2022 Dec;68:104153. doi: 10.1016/j.msard.2022.104153. Epub 2022 Aug 29. Mult Scler Relat Disord. 2022. PMID: 36081277 Free PMC article.
49 results